AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 290: H232-H239, 2006. First published August 26, 2005; doi:10.1152/ajpheart.00457.2005
0363-6135/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/1/H232    most recent
00457.2005v2
00457.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindsey, M. L.
Right arrow Articles by Spinale, F. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindsey, M. L.
Right arrow Articles by Spinale, F. G.

Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction

Merry L. Lindsey,1 G. Patricia Escobar,1 Lawrence W. Dobrucki,2 Danielle K. Goshorn,1 Shenikqua Bouges,1 Joseph T. Mingoia,1 David M. McClister, Jr.,1 Haili Su,2 Joseph Gannon,3 Catherine MacGillivray,3 Richard T. Lee,3 Albert J. Sinusas,2 and Francis G. Spinale1,4

1Division of Cardiothoracic Surgery Research, Medical University of South Carolina, Charleston, South Carolina; 2Division of Cardiovascular Medicine, Department of Internal Medicine and Department of Diagnostic Radiology, Yale University School of Medicine, New Haven, Connecticut; 3Cardiovascular Division, Department of Medicine Brigham and Women's Hospital and Harvard Medical School, Cambridge, Massachusetts; and 4Ralph A. Johnson Veterans Administration Medical Center, Charleston, South Carolina

Submitted 6 May 2005 ; accepted in final form 19 August 2005

Matrix metalloproteinases (MMPs) are postulated to be necessary for neovascularization during wound healing. MMP-9 deletion alters remodeling postmyocardial infarction (post-MI), but whether and to what degree MMP-9 affects neovascularization post-MI is unknown. Neovascularization was evaluated in wild-type (WT; n = 63) and MMP-9 null (n = 55) mice at 7-days post-MI. Despite similar infarct sizes, MMP-9 deletion improved left ventricular function as evaluated by hemodynamic analysis. Blood vessel quantity and quality were evaluated by three independent studies. First, vessel density was increased in the infarct of MMP-9 null mice compared with WT, as quantified by Griffonia (Bandeiraea) simplicifolia lectin I (GSL-I) immunohistochemistry. Second, preexisting vessels, stained in vivo with FITC-labeled GSL-I pre-MI, were present in the viable but not MI region. Third, a technetium-99m-labeled peptide (NC100692), which selectively binds to activated {alpha}v{beta}3-integrin in angiogenic vessels, was injected into post-MI mice. Relative NC100692 activity in myocardial segments with diminished perfusion (0–40% nonischemic) was higher in MMP-9 null than in WT mice (383 ± 162% vs. 250 ± 118%, respectively; P = 0.002). The unique finding of this study was that MMP-9 deletion stimulated, rather than impaired, neovascularization in remodeling myocardium. Thus targeted strategies to inhibit MMP-9 early post-MI will likely not impair the angiogenic response.

leukocytes; remodeling; imaging


Address for reprint requests and other correspondence: M. L. Lindsey, Cardiothoracic Surgery, Rm. 629, Strom Thurmond Research Bldg., 770 MUSC Complex, Medical Univ. of South Carolina, 114 Doughty St., PO Box 250778, Charleston, SC 29425 (e-mail: lindseym{at}uthscsa.edu)




This article has been cited by other articles:


Home page
 JNMHome page
B. L. Franc, P. D. Acton, C. Mari, and B. H. Hasegawa
Small-Animal SPECT and SPECT/CT: Important Tools for Preclinical Investigation
J. Nucl. Med., October 1, 2008; 49(10): 1651 - 1663.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol ImgHome page
A. J. Sinusas
Targeted Imaging Offers Advantages Over Physiological Imaging for Evaluation of Angiogenic Therapy
J. Am. Coll. Cardiol. Img., July 1, 2008; 1(4): 511 - 514.
[Full Text] [PDF]

Home page
 Physiol. Rev.Home page
F. G. Spinale
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
Physiol Rev, October 1, 2007; 87(4): 1285 - 1342.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Cretu, J. M. Roth, M. Caunt, A. Akalu, D. Policarpio, S. Formenti, P. Gagne, L. Liebes, and P. C. Brooks
Disruption of Endothelial Cell Interactions with the Novel HU177 Cryptic Collagen Epitope Inhibits Angiogenesis
Clin. Cancer Res., May 15, 2007; 13(10): 3068 - 3078.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
S. Goruppi, R. D. Patten, T. Force, and J. M. Kyriakis
Helix-Loop-Helix Protein p8, a Transcriptional Regulator Required for Cardiomyocyte Hypertrophy and Cardiac Fibroblast Matrix Metalloprotease Induction
Mol. Cell. Biol., February 1, 2007; 27(3): 993 - 1006.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. Bach-Gansmo, R. Danielsson, A. Saracco, B. Wilczek, T. V. Bogsrud, A. Fangberget, A. Tangerud, and D. Tobin
Integrin Receptor Imaging of Breast Cancer: A Proof-of-Concept Study to Evaluate 99mTc-NC100692
J. Nucl. Med., September 1, 2006; 47(9): 1434 - 1439.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
P. Kanellakis, N. J. Slater, X.-J. Du, A. Bobik, and D. J. Curtis
Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction
Cardiovasc Res, April 1, 2006; 70(1): 117 - 125.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.